Skip to content
10-Q

Quarterly Report

Oncolix, Inc.

0001477932-18-005683

← back to feed
Filed
Nov 19, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 12, 2018 114.23M sh
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$1.32M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $123.3K
Cash And Equivalents Q3 2018 · Dec 31, 2017 $494.41K
Stockholders Equity Q3 2018 · Sep 30, 2018 −$7.3M
Stockholders Equity Q3 2018 · Dec 31, 2017 −$1.64M
Current Liabilities Q3 2018 · Sep 30, 2018 $6.33M
Current Liabilities Q3 2018 · Dec 31, 2017 $1.26M
Total Liabilities Q3 2018 · Sep 30, 2018 $7.6M
Total Liabilities Q3 2018 · Dec 31, 2017 $2.53M
Current Assets Q3 2018 · Sep 30, 2018 $291.18K
Current Assets Q3 2018 · Dec 31, 2017 $889.4K
Total Assets Q3 2018 · Sep 30, 2018 $296.64K
Total Assets Q3 2018 · Dec 31, 2017 $889.4K
Sga Expense Q3 2018 · Sep 30, 2018 $221.63K
Sga Expense Q3 2018 · Sep 30, 2018 $815.45K
Rd Expense Q3 2018 · Sep 30, 2018 $211.2K
Rd Expense Q3 2018 · Sep 30, 2018 $379.09K
Net Income Q3 2018 · Sep 30, 2018 −$1.06M
Net Income Q3 2018 · Sep 30, 2018 −$5.98M